The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000277.3(PAH):c.353-7_353-5dup

CA607158216

552806 (ClinVar)

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: 3b55f0dd-a124-4ea0-bba1-761b9e0cda01
Approved on: 2023-07-23
Published on: 2023-07-23

HGVS expressions

NM_000277.3:c.353-7_353-5dup
NM_000277.3:c.353-7_353-5dupGTT
NM_000277.3(PAH):c.353-7_353-5dup
NC_000012.12:g.102877556_102877558dup
CM000674.2:g.102877556_102877558dup
NC_000012.11:g.103271334_103271336dup
CM000674.1:g.103271334_103271336dup
NC_000012.10:g.101795464_101795466dup
NG_008690.1:g.45046_45048dup
NG_008690.2:g.85854_85856dup
ENST00000553106.6:c.353-7_353-5dup
ENST00000307000.7:c.338-7_338-5dup
ENST00000549111.5:n.449-7_449-5dup
ENST00000550978.6:n.337-7_337-5dup
ENST00000551337.5:c.353-7_353-5dup
ENST00000551988.5:n.442-7_442-5dup
ENST00000553106.5:c.353-7_353-5dup
NM_000277.1:c.353-7_353-5dup
NM_000277.2:c.353-7_353-5dup
NM_001354304.1:c.353-7_353-5dup
NM_001354304.2:c.353-7_353-5dup

Uncertain Significance

Met criteria codes 1
PM2_Supporting
Not Met criteria codes 2
BP4 PP3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The NM_000277.3:c.353-7_353-5dup variant in PAH is an intronic variant affecting 3 nucleotides in intron 3. To our knowledge, this variant has not been reported in the literature and results of functional studies are unavailable. The highest population minor allele frequency in gnomAD v2.1.1 is 0.00005782 (2/34590 alleles) in the Latino/Admixed American population, which is lower than the ClinGen PAH VCEP’s threshold for PM2_Supporting (<0.0002), meeting this criterion (PM2_Supporting). The computational splicing predictor SpliceAI gives a score of 0.28 for acceptor loss which is neither above nor below the thresholds predicting an impact (>0.5) or no impact (<0.2) on PAH splicing. There is a ClinVar entry for this variant (Variation ID: 552806, 1 star review status) with one submitter classifying the variant as a variant of uncertain significance and one submitter classifying the variant as likely benign. In summary, this variant meets the criteria to be classified as a variant of uncertain significance for PAH deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen PAH Variant Curation Expert Panel (Specifications Version 2.0): PM2_Supporting.
Met criteria codes
PM2_Supporting
The highest population minor allele frequency in gnomAD v2.1.1 is 0.00005782 (2/34590 alleles) in the Latino/Admixed American population, which is lower than the ClinGen PAH VCEP’s threshold for PM2_Supporting (<0.0002), meeting this criterion (PM2_Supporting).
Not Met criteria codes
BP4
Intronic variant, SpliceAI predicts altered splicing of intron 3 (acceptor loss, -6bp, score 0.28; donor loss, -94bp, score 0.26); scores are <0.5 cutoff for PP3 but >0.2 cutoff for BP4
PP3
Intronic variant, SpliceAI predicts altered splicing of intron 3 (acceptor loss, -6bp, score 0.28; donor loss, -94bp, score 0.26); scores are <0.5 cutoff for PP3 but >0.2 cutoff for BP4
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.